1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A5EC05226EDF0C5C85257552006D8295
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-pharmaceutical-biotechnology-ma-integration-excellence-what-bio-pharma-commpanies-need-to-know?opendocument
18
19opendocument
2052.23.234.7
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services

White Paper: Pharmaceutical & Biotechnology M&A Integration Excellence: What Bio-pharma Companies Need to Know

Whitepaper Image

ID: GBC-WP20


Pages/Slides: 11


Published: Pre-2014


Delivery Format: PDF


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS

Please click on
"Buy Now" to obtain the white paper on "M&A Integration Excellence: What Bio-Pharma Companies Need to Know."
If you would like to purchase the full study this summary is based on click here.

Industries Profiled:
Manufacturing; Medical Device; Pharmaceutical; Biotech; Health Care


Companies Profiled:
3M; Nizhpharm; Takeda Pharmaceuticals; Solvay Pharmaceuticals; Merial; Pfizer; Eli Lilly; Covidien; Abbott Laboratories; Baxter Healthcare; Alexza Pharmaceuticals